All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
KYTH / Kythera Biopharma
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVNR / Avanir Pharmaceuticals Inc
|
|
|
|
|
|
|
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PCYC / Pharmacyclics
|
|
|
|
|
|
|
|
AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
Arrowhead Research Corp.
/ (042797209) |
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
FMI / Foundation Medicine, Inc.
|
|
|
|
|
|
|
|
GALT / Galectin Therapeutics Inc.
|
|
|
|
|
|
|
|
ITMN /
|
|
|
|
|
|
|
|
Ligand Pharmaceuticals Inc.
/ CLASS B (53220K207) |
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
Ventrus Biosciences, Inc.
/ (922822101) |
|
|
|
|
|
|
|
Incyte Genomics Notes 4.75% 10/1/2015 144A
/ CONV BONDS (45337CAH5) |
|
|
|
|
|
|
|
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
|
|
|
|
|
|
|
|
Intermune Inc Notes 5% 3/1/15
/ CONV BONDS (45884XAD5) |
|
|
|
|
|
|
|
Intermune Inc Notes 2.5% 12/15/17
/ CONV BONDS (45884XAF0) |
|
|
|
|
|
|
|
Salix 2.75% 5/15/15
/ CONV BONDS (795435AC0) |
|
|
|
|
|
|
|
795435AE6 / Salix Pharmaceuticals Inc. Bond 1.5% 3/15/19
|
|
|
|
|
|
|
|
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
|
|
|
|
|
|
|
|
GEVA / Synageva Biopharma Corp
|
|
|
|
|
|
|
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
MEI Pharma, Inc.
/ (55279B103) |
|
|
|
|
|
|
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
CERS / Cerus Corporation
|
|
|
|
|
|
|
|
DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
RCPT / Receptos, Inc.
|
|
|
|
|
|
|
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ZIOP / Alaunos Therapeutics Inc
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
375558AP8 / Gilead Sciences, Inc. Bond 1.625% 5/1/16
|
|
|
|
|
|
|
|
58501NAA9 / Medivation, Inc. 2.625% Bond 4/1/17
|
|
|
|
|
|
|
|
XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
02318X100 / Ambit Biosciences Corp
|
|
|
|
|
|
|
|
OSIR / Osiris Therapeutics, Inc.
|
|
|
|
|
|
|
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
SLXP / Salix Therapeuticals, Inc.
|
|
|
|
|
|
|
|
MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
STML / Stemline Therapeutics, Inc.
|
|
|
|
|
|
|
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
QCOR /
|
|
|
|
|
|
|
|
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
05334DAA5 / Auxilium Pharmaceuticals Inc 1.5% Bond due 2018-07-15
|
|
|
|
|
|
|
|
Viropharma Inc.
/ (928241108) |
|
|
|
|
|
|
|
TRGT / Targacept
|
|
|
|
|
|
|
|
CBST /
|
|
|
|
|
|
|
|
ARIA / ARIAD Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
|
|
|
|
|
CHTP / Chelsea Therapeutics International, Ltd.
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
VXRT / Vaxart, Inc.
|
|
|
|
|
|
|
|
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
|
|
|
|
|
|
|
|
XOMA / XOMA Royalty Corporation
|
|
|
|
|
|
|
|
BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
|
|
|
|
|
0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GERN / Geron Corporation
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|